Analyst Ratings for CVS Health Corp. (CVS)

Updated: 2017-07-28

Analysts covering CVS Health Corp. (NYSE:CVS) have given it a consensus rating of Overweight. CVS had previously received a consensus rating of Overweight a month ago.

A buy rating was issued by 16 analysts, 1 gave an overweight rating, 8 issued a hold rating, 0 issued an underweight rating, and 0 issued a sell rating. Compared to three months ago, there has been an decrease of 1 in the number of analysts with a positive outlook on the stock. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.

Investment analysts gave a few price targets for CVS. The most optimistic price target was 109, which equates to a potential upside of 38.11 percent. The lowest price target was 77, implying potential capital losses of -2.43 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. That number becomes -0.76 percent if we expand the time horizon to include the past 3 months instead of just one. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0 percent, as compared to a month ago. If we look at the last 90 days instead, we find a net average change of 0.17 percent in FY estimates.

Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, while 0 analysts revised their estimates downwards. Also over the last month, 3 analysts increased their estimates for the FY earnings, compared to 0 analysts that revised their FY estimates downwards.

CVS has an estimated earnings growth rate of 23.24 percent as forecasted by analysts. People on Wall Street often look at a company's PEG ratio. Smaller PEG ratios are desirable, because people typically see that as an indicator of higher growth relative to stock price. PEG ratios below 1 are often considered desirable, but many choose to perform ratio comparisons with other companies in the industry. The PEG ratio of CVS is 0.71.

In the trailing 52-weeks, CVS hit 98.66 at the highest peak, while it's lowest trading point was 69.30. The current market price is above the trailing year's low by 13.88 percent, and 20.01 percent lower than its 52-week high. CVS has a P/E ratio of 16.44. Investors typically compare the P/E ratio to a company's peers in the industry. The CVS value stock report compares CVS to some of its peers using value stock charts. The stock has a market capitalization of $79.76 billion. CVS's next earnings release will be on 0000-00-00, which is days away.